- $3.85m
- $3.88m
Annual balance sheet for IR-MED, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1.87 | 2.81 | 3 | 0.767 | 0.129 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.218 | 0.067 | 0.055 | 0.051 | 0.054 |
Prepaid Expenses | |||||
Total Current Assets | 2.08 | 2.88 | 3.06 | 0.848 | 0.205 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.006 | 0.031 | 0.226 | 0.14 | 0.035 |
Other Long Term Assets | |||||
Total Assets | 2.09 | 2.94 | 3.29 | 0.999 | 0.251 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.523 | 0.395 | 0.662 | 0.473 | 0.545 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.689 | 0.572 | 0.702 | 0.634 | 0.545 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 1.4 | 2.37 | 2.59 | 0.365 | -0.294 |
Total Liabilities & Shareholders' Equity | 2.09 | 2.94 | 3.29 | 0.999 | 0.251 |
Total Common Shares Outstanding |